tirzepatide insurance eli lilly direct compounded to sell Zepbound directly to consumers without coverage Big news! Eli Lilly just – Eli Lilly wants to replace – Tirzepatide Weight Loss Injections Near

Medications: Wegovy and Ozempic: These drugs mimic GLP-1's effects, helping people with obesity or diabetes control their weight and blood sugar

But three new Cochrane reviews on the effects of these drugs on adults with obesity raise concerns about long-term outcomes, side effects, and conflicts of interest from industry-funded studies

Mater 31 (22), 2100355

GLP-1s receptor agonists include semaglutide, marketed as Wegovy and Ozempic by Novo Nordisk, and tirzepatide, manufactured by US-based Eli Lilly under the brand name Mounjaro

Vascular and angiogenic research represents a third major thread

It is not medical advice and not a treatment plan